GRIA2 antibody (AA 35-175)
Quick Overview for GRIA2 antibody (AA 35-175) (ABIN5611163)
Target
See all GRIA2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 35-175
-
Purpose
- GRIA2 Antibody
-
Purification
- Purified antibody
-
Immunogen
- Purified recombinant fragment of human GRIA2 (AA: 35-175) expressed in E. Coli.
-
Isotype
- IgG2b
-
-
-
-
Application Notes
-
ELISA: 1/10000
FCM: 1/200 - 1/400
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified antibody in PBS with 0.05 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
- GRIA2 (Glutamate Receptor, Ionotropic, AMPA 2 (GRIA2))
-
Alternative Name
- GRIA2
-
Background
-
Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. This gene product belongs to a family of glutamate receptors that are sensitive to alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA), and function as ligand-activated cation channels. These channels are assembled from 4 related subunits, GRIA1-4. The subunit encoded by this gene (GRIA2) is subject to RNA editing (CAG->CGG, Q->R) within the second transmembrane domain, which is thought to render the channel impermeable to Ca(2+). Human and animal studies suggest that pre-mRNA editing is essential for brain function, and defective GRIA2 RNA editing at the Q/R site may be relevant to amyotrophic lateral sclerosis (ALS) etiology. Alternative splicing, resulting in transcript variants encoding different isoforms, (including the flip and flop isoforms that vary in their signal transduction properties), has been noted for this gene.
-
Molecular Weight
- 99 kDa
-
Gene ID
- 2891
-
UniProt
- P42262
-
Pathways
- PI3K-Akt Signaling
Target
-